These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1740047

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W, Szepietowski T.
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [Abstract] [Full Text] [Related]

  • 3. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J, Koch KM.
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract] [Full Text] [Related]

  • 4. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C.
    Bull Mem Acad R Med Belg; 1988 Jul; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. beta 2-Microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type.
    Van Ypersele de Strihou C.
    Nephrol Dial Transplant; 1996 Jul; 11 Suppl 2():147-9. PubMed ID: 8804017
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dialysis-related amyloidosis and clinical significance of extracorporeal removal of beta2-microglobulin.
    Gejyo F, Suzuki S, Arakawa M.
    Ther Apher; 1997 May; 1(2):126-8. PubMed ID: 10225756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dialysis-associated amyloidosis.
    Sethi D.
    Ren Fail; 1993 May; 15(3):349-51. PubMed ID: 8516489
    [Abstract] [Full Text] [Related]

  • 14. beta 2-microglobulin and amyloidosis: who is at risk?
    Davison AM.
    Nephrol Dial Transplant; 1995 May; 10 Suppl 10():48-51. PubMed ID: 8825433
    [No Abstract] [Full Text] [Related]

  • 15. Dialysis amyloidosis: current disease concepts and new perspectives for its treatment.
    Gejyo F, Arakawa M.
    Contrib Nephrol; 1990 May; 78():47-59; discussion 59-60. PubMed ID: 2225843
    [No Abstract] [Full Text] [Related]

  • 16. Clinical aspects of dialysis-related amyloidosis.
    Schäffer J, Floege J, Koch KM.
    Contrib Nephrol; 1995 May; 112():90-6. PubMed ID: 7554997
    [No Abstract] [Full Text] [Related]

  • 17. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J.
    Przegl Lek; 2006 May; 63(7):567-72. PubMed ID: 17203811
    [Abstract] [Full Text] [Related]

  • 18. [Amyloidosis in patients undergoing long-term hemodialysis: elucidation of etiological mechanism and therapeutic stratigy].
    Shimojyo F.
    Nihon Naika Gakkai Zasshi; 2005 Feb 20; 94 Suppl():56-60. PubMed ID: 15796057
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.